July 28, 2021 00:08 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Javed Akhtar defamation: Mumbai court gives 'last chance' to Kangana Ranaut, asks her to attend next hearing | Ex-CBI special director Rakesh Asthana appointed Delhi Police Commissioner | US Secretary of State Antony Blinken arrives in India, to hold talks with leaders tomorrow | BJP picks up Basavaraj Bommai as new CM for Karnataka, Yediyurappa congratulates his successor | Tokyo Olympics 2020: Indian shooters disappoint, make early exits

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.

India's Glenmark launches first oral antiviral drug FabiFlu to treat COVID-19 patients

New Delhi/IBNS: Amid the massive spike in number of cases, India-based pharmaceutical company 'Glenmark Pharmaceuticals' has launched antiviral drug Favipiravir, to be sold under the brand name FabiFlu, for the treatment of patients having mild to moderate COVID-19 symptoms.